{
    "title": "Washington EDU on Vitamin D",
    "slug": "washington-edu-on-vitamin-d",
    "aliases": [
        "/Washington+EDU+on+Vitamin+D",
        "/500"
    ],
    "tiki_page_id": 500,
    "date": "2010-07-01",
    "categories": [
        "Overview for doctors"
    ],
    "tags": [
        "CKD",
        "Overview for doctors",
        "bacteria",
        "blood levels",
        "bone",
        "bone cancer",
        "breast cancer",
        "breathing",
        "cancer",
        "colon cancer",
        "cystic fibrosis",
        "falls fractures",
        "kidney",
        "life span",
        "lymphoma",
        "mortality",
        "ovarian cancer",
        "prostate cancer",
        "rickets",
        "tuberculosis",
        "vitamin d",
        "vitamin d blood test"
    ]
}


<h2><a href="http://courses.washington.edu/bonephys/opvitD.html">courses.washington.edu/bonephys/opvitD.html</a><br />

Updated April 2010Â  Downloaded July 2010</h2>

<h1>Vitamin D requirements</h1>

<p>There are three sources of vitamin D: natural sunlight, fortification of  dietary foods, particularly dairy products and some cereals and oily  fish.  The radiation that converts vitamin D in the skin is the same  wavelength that causes sunburn, so careful application of sunscreen can  inhibit vitamin D production.   At northern latitudes, there is not  enough radiation to convert vitamin D, especially during the winter.   After the age of 70 the skin does not convert vitamin D effectively (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=2997282&dopt=abstract">MacLaughlin  J</a>). Vitamin D levels depend on the  pigmentation in the skin  (darker skinned people have lower vitamin D levels), the altitude  (higher levels in the mountains), and body weight (obese people have  lower levels than thin people).</p>

<table cellspacing="3" cellpadding="4" border="0" bgcolor="#ffffff"><tbody><tr bgcolor="#99ffcc" align="center"><td height="40" colspan="2">Vitamin  D supplementation</td>

</tr><tr><th>People with poor sunlight exposure</th>

<th>400-1000  units/day</th>

</tr><tr><th>Adults older than 70</th>

<th>800-1000 units/day</th>

</tr><tr><th>Patients with cystic fibrosis</th>

<th>800-1000  units/day</th>

</tr><tr><th>Patients with malabsorption</th>

<th>Up to 50,000  units/day, check levels</th>

</tr><tr><th>Patients with liver disease</th>

<th>May need active  metabolites</th>

</tr><tr><th>Patients with kidney disease</th>

<th>Need active  metabolites</th>

</tr><tr><th>Patients with sarcoidosis <br />

or kidney stones</th>

<th>Be careful not to give excess<br />

Check  levels, don't exceed 30 ng/mL</th>

</tr></tbody></table><p>Many vitamin D supplements also contain high contents of vitamin A - and  recent studies show that <a href="http://courses.washington.edu/bonephys/opnutr.html#vitA">vitamin A</a>  can increase bone resorption.  The labels do not have to list the  vitamin A, but it is often there, especially if it comes from cod liver  oil.</p>

<p>Cholecalciferol is preferred because it sustains blood levels for  a longer time  (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=15531486&dopt=abstract">Armas,</a>  <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=19631774&dopt=abstract">Glendenning  P</a>).</p>

<a></a> <hr /><h2>Vitamin D levels in serum</h2>

<table cellspacing="3" cellpadding="3" border="0" bgcolor="#ffffff"><tbody><tr bgcolor="#99ffcc" align="center"><td height="40">25 (OH) D  Level</td>

<td>ng/ml <br />

(used in USA)</td>

<td>nMol/L<br />

(international)</td>

</tr><tr><th>Deficient</th>

<th>less than 8</th>

<th>less than 20</th>

</tr><tr><th>Insufficient</th>

<th>8-20</th>

<th>20-50</th>

</tr><tr><th>Optimal</th>

<th>20-60</th>

<th>50-150</th>

</tr><tr><th>High</th>

<th>60-90</th>

<th>150-225</th>

</tr><tr><th>Toxic</th>

<th>greater than 90</th>

<th>greater than 225</th>

</tr></tbody></table><p><img src="http://courses.washington.edu/bonephys/Gallery/VitDsurfer.jpg" alt="image" width="723" height="404">  <br /><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=17426097&dopt=abstract">Binkley  N</a>, <span class="grey">Low Vitamin D status despite abundant sun  exposure. <br />

J Clin Endocrinol Metab 92:2130, 2007. copyright 2007,  The Endocrine Society</span></p>

<p>The above graph shows results from 93 healthy 24-year-old  Hawaiian surfers.  The authors of this paper concluded that: "the goal  of vitamin D replacement therapy should be no greater than the maximum that appears attainable, a serum 25(OH)D concentration of approximately 60 ng/ml."  However, many laboratories currently have listed their  "sufficient" range as 32-150 ng/ml.  There is no evidence that levels  above 60 ng/ml are beneficial.</p>

<p>There is disagreement about whether the lower limit of the  optimal vitamin D levels should be 20 or 30 ng/ml, but none of the  experts in the field still think that levels lower than 20 ng/ml are  desirable.  This is really different from ten years ago, when levels  above 15 ng/dl were considered sufficient.</p>

<p>In another paper,   <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=18319318&dopt=abstract">Binkley  N</a> found differences among the laboratory tests for 25(OH) vitamin D  of around 5 ng/dL, and approximately 10% error within the same lab.   These errors must be taken into account when interpreting the vitamin D  levels.  <a></a></p>

<hr /><h2>Vitamin D metabolism</h2>

<p><span class="grey">Here is a little Flash slide show about vitamin D  formation and actions:</span></p>

ject width="610px" height="420px" align="middle" id="vitd" codebase="http://fpdownload.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=7,0,0,0" classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000">

<em>bed width="610px" height="420px" align="middle" pluginspage="http://www.macromedia.com/go/getflashplayer" type="application/x-shockwave-flash" allowscriptaccess="sameDomain" name="vitd" bgcolor="#ffffff" quality="high" src="http://courses.washington.edu/bonephys/Gallery/vitd.swf">  <a href="http://courses.washington.edu/bonephys/Gallery/vitd.swf"><img src="http://courses.washington.edu/bonephys/downlo.gif" alt="image" width="56" height="50"></a> </em>

<table cellpadding="5" border="1"><tbody><tr><td>

<h2>Measure 25(OH) vitamin D, NOT 1,25(OH)<sub>2</sub> vitamin D</h2>

<p>1,25(OH)<sub>2</sub> vitamin D <span>[1,25-D]</span> is more difficult and expensive  to measure than 25(OH)D; moreover, it is not a good measure of vitamin D  status.  When patients are vitamin D deficient, the parathyroid hormone  increases and drives the renal 1-alpha-hydroxylase, so that 1,25-D  levels increase.  Only in severe deficiency, when substrate is depleted,  does the 1,25-D  become low.  Partially treated vitamin D deficiency  also results in marked elevations of 1,25-D levels.   <br /><br />

Some doctors, thinking they are sophisticated because they know  that 1,25-D is more active, order the wrong measurement.  Do not fall  into this trap and waste money on this expensive but often misleading  test!  There are only <b> a few situations where you would actually want  to know the 1,25-D:</b>  <i>  <br />

unexplained hypercalcemia (looking for granulomatous disease  or lymphoma),  <br />

suspected genetic childhood rickets,  <br />

suspected tumor-induced osteomalacia,  <br />

some cases of nephrolithiasis or hypercalciuria. </i> <br /><br />

Patients with stages 4-5 chronic kidney disease have decreased  1,25-D levels but even in those patients the 25(OH) vitamin D is a  better test of the stores of vitamin D, and the PTH is a better  indicator of mineral abnormalities. <br /><br />

Finally, some cells generate <b>intracellular </b>1,25-D  to  fight  tuberculosis, suppress cancer growth, or modify immune response.   They need adequate substrate, as measured by 25(OH) vitamin D.</p>

</td>

</tr></tbody></table><em><a></a> </em>

<h2><em>Vitamin D and Mortality</em></h2>

<p><em><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=18695076&dopt=abstract">Melamed  ML</a> followed 13,331 adults in the US for 8.7 years to see if the  vitamin D level was related to mortality.  Notice that the mortality  increases with either high or low levels of vitamin D (just like some of  the other steroid hormones). <img src="http://courses.washington.edu/bonephys/Gallery/Dmortality.jpg" alt="image" width="569" height="421"> <br /><span class="grey"> copyright American Medical Association, used  with permission</span></em></p>

<p><em>Another  study (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=18574092&dopt=abstract">Dobnig  H</a>) from Germany found lower mortality in people in the top 25% of  vitamin D levels, compared to those with the lower 25%.  The overall  levels, however, were quite low; almost everybody was lower than 33  ng/ml.</em></p>

<p><em><a href="http://courses.washington.edu/bonephys/Graphs/vitMortality.jpg"><img src="http://courses.washington.edu/bonephys/Graphs/vitMortalityL.jpg" alt="image" width="144" height="119"></a>     A meta-analysis of  clinical trials of vitamin D (average dose was  about 500 units/day) found an overall reduction in mortality of 7%  (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=17846391&dopt=abstract">Autier  P</a>).</em></p>

<p><em>Click to enlarge this Forest Plot of mortality from randomized  trials of vitamin D.  Overall there was a non-significant decrease of 7%  in the vitamin D groups compared to placebo (<a href="http://www.ahrq.gov/Clinic/tp/vitadcaltp.htm">Chung</a>) This  report was sponsored by the US Agency for Healthcare Research and  Quality.  <a></a></em></p>

<hr /><h2><em>Vitamin D and fractures</em></h2>

<em>ject width="610px" height="420px" align="middle" id="vitd" codebase="http://fpdownload.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=7,0,0,0" classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000">

<em>bed width="610px" height="420px" align="middle" pluginspage="http://www.macromedia.com/go/getflashplayer" type="application/x-shockwave-flash" allowscriptaccess="sameDomain" name="vitd" bgcolor="#F0F8FF" quality="high" src="http://courses.washington.edu/bonephys/Gallery/vitDfxrisk.swf">  </em></em>

<p>

</p><table><tbody><tr><td><a href="http://courses.washington.edu/bonephys/Tables/VitDTable.xls"><img src="http://courses.washington.edu/bonephys/Tables/vitDbrief.gif" alt="image" width="335" height="518"></a></td>

<td>This table shows overall results of studies of vitamin D and  fracture rates.  Most of the studies did not find a signficant benefit  of vitamin D.  <br /><br /><b> Click on the table to download an Excel file with more  details.</b>  <br /><br />

Recently there have been several meta-analyses of this topic,  which show different points of view.   After reading these studies and  analyses, I conclude that vitamin D therapy can reduce fractures in  frail elderly patients, especially when they have vitamin D insuffiency,  and that adequate calcium intake is also needed.  Otherwise, the  difference in fracture rates is really quite modest in the vitamin D  clinical trials.</td>

</tr></tbody></table><em><em><a></a></em></em>

<hr /><h2><em><em>Vitamin D and cancer</em></em></h2>

<p><em><em>Vitamin D can suppress growth of cancer cells grown in culture.   Therefore, researchers have tried to determine whether vitamin D levels  are associated with cancer, and whether vitamin D could be used to  prevent or treat cancer.  Early studies were promising, but recent  larger studies do not find the same encouraging results.  Click to see  recent large prospective observational studies relating vitamin D to  colon, breast, or prostate cancer:   	ject width="520" height="450" align="middle" id="vitDcancer" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=10,0,0,0" classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000">

<em>bed width="520" height="450" align="middle" pluginspage="http://www.adobe.com/go/getflashplayer" type="application/x-shockwave-flash" allowfullscreen="false" allowscriptaccess="sameDomain" name="vitDcancer" bgcolor="#ffffff" quality="high" src="http://courses.washington.edu/bonephys/Gallery/vitDcancer.swf"> 	</em></em></em></p>

<h3><em><em><em>Colon cancer</em></em></em></h3>

<p><em><em><em><a href="http://courses.washington.edu/bonephys/Graphs/vitDColon.jpg"><img src="http://courses.washington.edu/bonephys/Graphs/vitDColonL.jpg" alt="image" width="122" height="136"></a>  Vitamin D probably protects against colon cancer (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=18990737&dopt=abstract">Wei  MY</a>, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=18290728&dopt=abstract">Giovannucci  E</a>,<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=17971526&dopt=abstract">Freedman  DM</a>).  Click to enlarge this Forest Plot of colon cancer from studies of  vitamin D.  (<a href="http://www.ahrq.gov/Clinic/tp/vitadcaltp.htm">Chung</a>)  This report was sponsored by the US Agency for Healthcare Research and  Quality.  Since then, a large nested case-control study in Europe found  an increased risk in men with low vitamin D (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=20093284&dopt=abstract">Jenab  M</a>; results are shown on the image above).  Another study looking at  different ethnic groups also found lower risk of those in the lowest  quintile of vitamin D (less than 16.8 ng/ml), but no difference in the  other 80% of patients (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=20056631&dopt=abstract">Woolcott  CG</a>).</em></em></em></p>

<h3><em><em><em>Breast Cancer</em></em></em></h3>

<p><em><em><em><img src="http://courses.washington.edu/bonephys/Tables/vitDbreastCA.jpg" alt="image" width="769" height="318"></em></em></em></p>

<p><em><em><em>( <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=17974532&dopt=abstract">Abbas  S</a>, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=20022237&dopt=abstract">Agborsangaya  CB</a>, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=20112341&dopt=abstract">Almquist  M</a>,  <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=16103450&dopt=abstract">Bertone-Johnson  ER</a>,  <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=18381472&dopt=abstract">Freedman  DM</a>, <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=19715600&dopt=abstract">McCullough  ML</a>)</em></em></em></p>

<p><em><em><em><a href="http://courses.washington.edu/bonephys/Graphs/vitDbreastCAWHI.jpg"><img src="http://courses.washington.edu/bonephys/Graphs/vitDbreastCAWHIL.jpg" alt="image" width="108" height="93"></a>  In the Women's Health Initiative randomized clinical trial of calcium  and vitamin D, which included 36,000 women, there was no difference in  the incidence of breast cancer between those assigned to placebo or to  calcium and vitamin D (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=19001601&dopt=abstract">Chlebowski  RT</a>). Click on the thumbnail to enlarge the graph from that study.   However, if the intake of vitamin D included the supplements taken by  the subjects, then those with the highest intakes had <b>higher</b> risk  of breast cancer.</em></em></em></p>

<p><em><em><em>Â </em></em></em></p>

<h3><em><em><em>Prostate Cancer</em></em></em></h3>

<p><em><em><em><a href="http://courses.washington.edu/bonephys/Graphs/vitDProstate.jpg"><img src="http://courses.washington.edu/bonephys/Graphs/vitDProstateL.jpg" alt="image" width="108" height="119"></a>     Early studies suggested the men with low vitamin D levels were more  likely to get prostate cancer, but newer, larger studies do not find  this. Click to enlarge this Forest Plot of prostate cancer from studies  of vitamin D.  (<a href="http://www.ahrq.gov/Clinic/tp/vitadcaltp.htm">Chung</a>)  This report was sponsored by the US Agency for Healthcare Research and  Quality.  In the large Prostate, Lung, Colorectal and ovarian cancer  screening trial (PLCO), the risk of aggressive prostate cancer was  higher in men with higher vitamin D levels, as shown in the colored  graph above (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=18505967&dopt=abstract">Ahn  J</a>).  Two newer studies within the last year continue to show no  significant benefit of vitamin D - one was a case control study of men  with different ethnicities, including 329 cases (<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=20064705&dopt=abstract">Park  SY</a>) and the other a large nested case control study from the  European Prospective Investigation into Cancer and Nutrition (EPIC)  study, which included 652 cases ( <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=19359375&dopt=abstract">Travis  RC</a>).</em></em></em></p>